戻る Agenda
LS39: Utilization method of electronic data submitted for J-NDA filing
Session Chair(s)
Natsuko Hamada
Head of Regulatory Affairs, Swedish Orphan Biovitrum Japan, Japan
Speaker(s)
Daisuke Iwata
Office of Asia Training Center and International cooperation, Pharmaceuticals and Medical Devices Agency, Japan
Masayuki Tagami
Manager, Regulatory Strategy Group 2, Regulatory Affairs, Pfizer R&D Japan G.K., Japan